Approval of alteplase in Europe: will it change stroke management?
Kaste
Markku
M
Department of Neurology, Helsinki University Central Hospital, FIN-00029 HUS, Helsinki, Finland. markku.kaste@hus.fi <markku.kaste@hus.fi>
D017277:Drug Approval; D005060:Europe; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010818:Practice Patterns, Physicians'; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator